Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines
https://doi.org/10.47360/1995-4484-2025-129-137
Abstract
The article discusses the 2022 updated version of the collaborative ASAS/EULAR (Assessment in SpondyloArthritis international Society/European Alliance of Associations for Rheumatology) recommendations for the treatment of axial spondyloarthritis.
About the Authors
Sh. F. Erdes
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Shandor F. Erdes
115522, Moscow, Kashirskoye Highway, 34A
T. V. Dubinina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Tatiana V. Dubinina
115522, Moscow, Kashirskoye Highway, 34A
References
1. Federal Law No. 489-FZ dated 25.12.2018 “On the amendments to Article 40 of the Federal Law “On compulsory medical insurance in the Russian Federation” and the Federal Law “On the fundamentals of health protection of citizens in the Russian Federation” on issues of clinical guidelines” (In Russ.). URL: https://publication.pravo.gov.ru/Document/View/0001201812250098 (Accessed: 21st January 2025).
2. On the protection of citizens’ health in the Russian Federation: A selection of the most important documents for the request “On the protection of citizens’ health in the Russian Federation” (regulatory legal acts, forms, articles, expert consultations and much more) (In Russ.). URL: https:// www.consultant.ru/law/podborki/ob_ohrane_zdorovya_grazhdan_v_rossijskoj_federacii/ (Accessed: 21st January 2025).
3. Malyugin SV, Vinokurova AA. Clinical guidelines in the system of medical care in modern Russia: Theoretical statement and practical aspects. Lex Russica. 2023;76(7):28-47 (In Russ.). doi: 10.17803/1729-5920.2023.200.7.028-047
4. Andreeva IV, Stetsyuk OU, Egorova OA. Clinical guidelines: What the practitioner should know? RMJ. 2020;5:21-25 (In Russ.).
5. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68(6):777-783. doi: 10.1136/ard.2009.108233
6. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361-368. doi: 10.1002/art.1780270401
7. van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, et al. 2016 update of the ASASEULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770
8. Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19-34. doi: 10.1136/ard-2022-223296
9. Choufani M, Kay J, Ermann J. Axial spondyloarthritis guidelines – aiming for maximum impact. Curr Opin Rheumatol. 2024;36(4):251-260. doi: 10.1097/BOR.0000000000001020
10. van der Heijde D, Aletaha D, Carmona L, Edwards CJ, Kvien TK, Kouloumas M, et al. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations. Ann Rheum Dis. 2015;74(1):8-13. doi: 10.1136/annrheumdis-2014-206350
11. Seo MR, Yeo J, Park JW, Lee YA, Lee JH, Kang EH, et al.; Korean Society of Spondyloarthritis Research. Korean treatment recommendations for patients with axial spondyloarthritis. Korean J Intern Med. 2024;39(1):200. doi: 10.3904/kjim.2023.194.e1
12. Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F, et al. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis. 2014;73(8):1455-1461. doi: 10.1136/annrheumdis-2014-205178
13. Podryadnova MV, Balabanova RM, Urumova MM, Erdes ShF. Correlation between clinical characteristics of ankylosing spondylitis and work capacity and productivity. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014;52(5):513-519 (In Russ.). doi: 10.14412/1995-4484-2014-513-519
14. Ramonda R, Marchesoni A, Carletto A, Bianchi G, Cutolo M, Ferraccioli G, et al.; ATLANTIS study group. Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey. Arthritis Res Ther. 2016;18:78. doi: 10.1186/s13075-016-0977-2
15. Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68(6):784-788. doi: 10.1136/ard.2008.101501
16. Webers C, Nezam El-Din R, Beckers E, Been M, Vonkeman HE, van Tubergen A. Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice. Rheumatology (Oxford). 2025;64(1):91-98. doi: 10.1093/rheumatology/kead634
17. Bolt JW, Aalbers CJ, Walet L, van Mens LJJ, van Denderen C, van der Horst-Bruinsma I, et al. Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target. Rheumatology (Oxford). 2024;63(1):34-40. doi: 10.1093/rheumatology/kead155
18. Desthieux C, Molto A, Granger B, Saraux A, Fautrel B, Gossec L. Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: The DESIR cohort. Ann Rheum Dis. 2016;75(9):1661-1666. doi: 10.1136/annrheumdis-2015-208251
19. Feldtkeller E, Rudwaleit M, Zeidler H. Easy probability estimation of the diagnosis of early axial spondyloarthritis by summing up scores. Rheumatology (Oxford). 2013;52(9):1648-1650. doi: 10.1093/rheumatology/ket176
20. Wendling D, Lukas C, Paccou J, Claudepierre P, Carton L, Combe B, et al.; French Society for Rheumatology (SFR). Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis. Joint Bone Spine. 2014;81(1):6-14. doi: 10.1016/j.jbspin.2013.12.002
21. Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: Recommendations of an international task force. Ann Rheum Dis. 2014;73(1):6-16. doi: 10.1136/annrheumdis-2013-203419
22. Wendling D, Prati C, Sieper J. Disease activity in ankylosing spondylitis: The global therapeutic target. Ann Rheum Dis. 2018;77(8):1095-1096. doi: 10.1136/annrheumdis-2017-212363
23. Ortolan A, Webers C, Sepriano A, Falzon L, Baraliakos X, Landewé RB, et al. Efficacy and safety of non-pharmacological and non-biological interventions: A systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis. 2023;82(1):142-152. doi: 10.1136/ard-2022-223297
24. Rodríguez-Lozano C, Juanola X, Cruz-Martínez J, Peña-Arrébola A, Mulero J, Gratacós J, et al.; Spondyloarthropathies Study Group of the Spanish Society of Rheumatology. Outcome of an education and home-based exercise programme for patients with ankylosing spondylitis: A nationwide randomized study. Clin Exp Rheumatol. 2013;31(5):739-748
25. Braun J, Baraliakos X, Westhoff T. Nonsteroidal anti-inflammatory drugs and cardiovascular risk – a matter of indication. Semin Arthritis Rheum. 2020;50(2):285-288. doi: 10.1016/j.semarthrit.2019.07.012
26. Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016;68(2):282-298. doi: 10.1002/art.39298
27. Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, et al. 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71(10):1285-1299. doi: 10.1002/acr.24025
Review
For citations:
Erdes Sh.F., Dubinina T.V. Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines. Rheumatology Science and Practice. 2025;63(2):129-137. (In Russ.) https://doi.org/10.47360/1995-4484-2025-129-137
Views:
68
Email this article 